未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏SAKK 11/16, a phase IIa trial evaluating overall survival (OS) for recurrent/metastatic Head & neck squamous cell carcinoma (RMHNSCC) patients (pts) progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapy
Mach, N.; Fernandez, E.; Vernet, R.; Vonrohr, O.; Urwyler, M.; Charrier, E.; Belkouch, M. C.; Saingier, V.; Courtout, F.; De Vito, C.; Rubin, O.; Ancrenaz, V.; Grogg, J. N.; Renaux, J.; Gysel, K.; Mueller, G.; Brezina, T.; Rordorf, T.; Joerger, M.; Michielin, O. A.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environment开发优化的封闭和半自动协议,用于良好的制造规范在医院环境中制造肿瘤浸润淋巴细胞
Gannon, Philippe O.; Harari, Alexandre; Auger, Aymeric; Murgues, Clement; Zangiacomi, Vincent; Rubin, Olivier; Lavoie, Kim Ellefsen; Guillemot, Laurent; Rodrigo, Blanca Navarro; Nguyen-Ngoc, Tu; Rusakiewicz, Sylvie; Rossier, Laetitia; Boudousquie, Caroline; Baumgaertner, Petra; Zimmermann, Stefan; Trueb, Lionel; Iancu, Emanuela M.; Sempoux, Christine; Demartines, Nicolas; Coukos, George; Kandalaft, Lana E.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏